Sanofi Tapping AI To Help Consumers Manage IBS
Executive Summary
Sanofi is utilizing AI technology to help UK consumers to better manage their IBS and digestive symptoms.
You may also be interested in...
Kenvue Joins Digital Gut Health Revolution With UK Imodium App
Kenvue’s new Gut2Know app “empowers diarrhea sufferers to boost their gut knowledge and track and identify triggers for their symptoms, such as stress or diet,” the company says. With the launch, Kenvue joins other major players like Bayer and Sanofi who have recently invested in digital digestive health.
What A Relief! Three German IBS Launches From Sanofi, Dr Kade, Dr Loges
Sanofi on trend with plant-based, app-supported Buscopan line extension, Dr Kade offers all-in-one gastrointestinal product and Dr Loges appeals to children with blueberry flavored supplement.
Sanofi Personalizing IBS Treatment With Digital Therapy
Sanofi Consumer Healthcare has teamed up with digital health player Cara Care to offer an innovative treatment for IBS which goes beyond the pill and helps sufferers access personalized support for their illness.